ConductScience.org, home

Paper23318878

Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.

Amaral C and 7 others. J Steroid Biochem Mol Biol, 2013. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy. Papers, record 23318878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23318878

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
PubMed
Journal
J Steroid Biochem Mol Biol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2013-11-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amaral CCristina
2Varela CCarla
3Azevedo MMargarida
4da Silva ETElisiário Tavares
5Roleira FMFernanda M F
6Chen SShiuan
7Correia-da-Silva GGeorgina
8Teixeira NNatércia

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aromatase InhibitorsMajor topic
AutophagyMajor topic
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
TestosteroneMajor topic
Adenine
Androstanes
Cell Line, Tumor
Cell Survival
Drug Resistance, Neoplasm
Estrogen Antagonists
Female
Humans
MCF-7 Cells
Neoplasms, Hormone-Dependent
Phosphatidylinositol 3-Kinases

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
41977303Steroidogenic Acute Regulatory Protein in Breast Cancer: Mechanistic Insights into Pathogenesis and Therapeutics.Int J Mol Sci2026https://conductscience.org/library/papers/41977303PubMed
39857947New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment.Cancers (Basel)2025https://conductscience.org/library/papers/39857947PubMed
39201706Updates on Mechanisms of Cytochrome P450 Catalysis of Complex Steroid Oxidations.Int J Mol Sci2024https://conductscience.org/library/papers/39201706PubMed
38911541Steroidogenic cytochrome P450 enzymes as drug target.Toxicol Res2024https://conductscience.org/library/papers/38911541PubMed
37575061Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway.Am J Physiol Cell Physiol2023https://conductscience.org/library/papers/37575061PubMed
37173983Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors.Cancers (Basel)2023https://conductscience.org/library/papers/37173983PubMed
36677847An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on Sensitive and Resistant Cell Lines.Molecules2023https://conductscience.org/library/papers/36677847PubMed
35006438Cancer metabolism and intervention therapy.Mol Biomed2021https://conductscience.org/library/papers/35006438PubMed
34681208Design, Synthesis and Biological Evaluation of Aromatase Inhibitors Based on Sulfonates and Sulfonamides of Resveratrol.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34681208PubMed
32456259Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives.Int J Mol Sci2020https://conductscience.org/library/papers/32456259PubMed
30813476Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR.Int J Mol Sci2019https://conductscience.org/library/papers/30813476PubMed
26984766Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy.BMC Cancer2016https://conductscience.org/library/papers/26984766PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23318878

GET https://conductscience.org/api/papers/v1/23318878/authors